About ABSCINT
Molecular Imaging Diagnostics
ABSCINT is a clinical stage molecular imaging company developing in vivo diagnostics empowered by single-domain antibodies. Our name captures our essence, which is to address unmet medical needs with the development of unique antibodies (AB) providing superior performance in scintigraphy (SCINT). Our mission is to provide more precise, more specific, more convenient and safer diagnostics in the fields of oncology, cardiology and immunology.
ABSCINT focuses on the development of
radiolabelled single-domain antibodies for whole body molecular
imaging applications. Molecular imaging is used for the diagnosis of
disease, for molecular characterisation of a disease, for monitoring
treatment response and for detection of disease recurrence. It is based
on specific molecular markers that can be visualised over the entire
body by a short scan.
The company has two clinical stage products: one in oncology and one in cardiovascular disease.
